Congenital Heart Disease
Occlutech’s current and future products are based on patented technology.
The unique, patented braiding technology allows Occlutech to create products that are different by design, adding value to cardiac implants and occlusion products. Occlutech creates products that can be implanted in a high range of patients, avoiding open-heart surgery, while minimizing potentially fatal complications from e.g. erosion.1,2,3,4
Accessory Medical Devices
* Availability subjected to regulatory approval in certain countries.
- ASD_ALL_TRM_ver05; UNI_TRM_ver04; PDA_TRM_ver04; mVSD_TRM_ver04; PLD_TRM_ver03; PFO_TRM_ver03; AFR_HR_TRM_ver03
- CER_PDA_rev08; PLD_CER_ver09 ; PFO_ALL_CER_ver13 ; ASD_ALL_UNI_ver13; AFR_CER_rev03; CER_mVSD_rev_07
- “Occlutech patents”
- 2018_Kenny_A randomized, controlled, multi-center trial of the efficacy and safety of the Occlutech Figulla Flex-II Occluder compared to the Amplatzer Septal Occluder for transcatheter closure of secundum atrial septal defects